共有 50 笔近期内部人交易记录记录，涉及 NeuroPace, Inc. (NPCE), 包括 24 笔买入 和 25 笔卖出. 内部人买入总额为 $1.05M 内部人卖出总额为 $1.43M.
近期活跃的重要内部人包括 Morrell Martha, Fischer Frank M, Kumar Rakhi. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — NPCE
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2026-03-24 |
Morrell Martha |
Chief Medical Officer |
RSU 预扣税 |
1,341 |
$13.27 |
$17.8K |
47,283 |
| 2026-03-20 |
Fischer Frank M |
Director |
限制性股票授予 (RSU) |
1,826 |
$13.00 |
$23.74K |
595,177 |
| 2026-03-20 |
Kumar Rakhi |
Director |
限制性股票授予 (RSU) |
1,153 |
$13.00 |
$14.99K |
19,160 |
| 2026-03-20 |
Lacob Joseph |
Director |
限制性股票授予 (RSU) |
865 |
$13.00 |
$11.25K |
14,754 |
| 2026-03-20 |
Geiger Uri |
Director |
限制性股票授予 (RSU) |
913 |
$13.00 |
$11.87K |
14,858 |
| 2026-03-03 |
Becker Joel |
Chief Executive Officer |
RSU 预扣税 |
5,023 |
$13.83 |
$69.47K |
96,937 |
| 2026-03-03 |
Morrell Martha |
Chief Medical Officer |
RSU 预扣税 |
1,340 |
$13.83 |
$18.53K |
48,624 |
| 2026-02-27 |
Becker Joel |
Chief Executive Officer |
RSU 预扣税 |
1,126 |
$14.58 |
$16.42K |
101,960 |
| 2026-02-27 |
Morrell Martha |
Chief Medical Officer |
RSU 预扣税 |
358 |
$14.58 |
$5.22K |
74,964 |
| 2026-02-20 |
Morrell Martha |
Chief Medical Officer |
RSU 预扣税 |
3,412 |
$14.34 |
$48.93K |
75,322 |
| 2025-12-19 |
Lacob Joseph |
Director |
限制性股票授予 (RSU) |
678 |
$16.59 |
$11.25K |
13,889 |
| 2025-12-19 |
Fischer Frank M |
Director |
限制性股票授予 (RSU) |
1,431 |
$16.59 |
$23.74K |
593,351 |
| 2025-12-19 |
Geiger Uri |
Director |
限制性股票授予 (RSU) |
715 |
$16.59 |
$11.86K |
13,945 |
| 2025-12-19 |
Kumar Rakhi |
Director |
限制性股票授予 (RSU) |
904 |
$16.59 |
$15K |
18,007 |
| 2025-12-15 |
Morrell Martha |
Chief Medical Officer |
知情卖出 |
25,000 |
$15.97 |
$399.25K |
49,964 |
| 2025-12-03 |
Morrell Martha |
Chief Medical Officer |
RSU 预扣税 |
1,338 |
$16.66 |
$22.29K |
78,734 |
| 2025-11-27 |
Becker Joel |
Chief Executive Officer |
RSU 预扣税 |
1,126 |
$16.50 |
$18.58K |
103,086 |
| 2025-11-27 |
Morrell Martha |
Chief Medical Officer |
RSU 预扣税 |
357 |
$16.50 |
$5.89K |
80,072 |
| 2025-11-20 |
Morrell Martha |
Chief Medical Officer |
RSU 预扣税 |
3,051 |
$13.50 |
$41.19K |
80,429 |
| 2025-09-19 |
Lacob Joseph |
Director |
限制性股票授予 (RSU) |
1,131 |
$9.94 |
$11.24K |
13,211 |
| 2025-09-19 |
Fischer Frank M |
Director |
限制性股票授予 (RSU) |
2,389 |
$9.94 |
$23.75K |
591,920 |
| 2025-09-19 |
Geiger Uri |
Director |
限制性股票授予 (RSU) |
1,194 |
$9.94 |
$11.87K |
13,230 |
| 2025-09-19 |
Kumar Rakhi |
Director |
限制性股票授予 (RSU) |
1,509 |
$9.94 |
$15K |
17,103 |
| 2025-09-03 |
Morrell Martha |
Chief Medical Officer |
RSU 预扣税 |
1,337 |
$9.36 |
$12.51K |
83,480 |
| 2025-08-27 |
Becker Joel |
Chief Executive Officer |
RSU 预扣税 |
1,126 |
$8.88 |
$10K |
104,212 |
| 2025-08-27 |
Morrell Martha |
Chief Medical Officer |
RSU 预扣税 |
357 |
$8.88 |
$3.17K |
84,817 |
| 2025-08-20 |
Morrell Martha |
Chief Medical Officer |
RSU 预扣税 |
3,052 |
$8.66 |
$26.43K |
85,174 |
| 2025-06-21 |
Lacob Joseph |
Director |
限制性股票授予 (RSU) |
1,080 |
$10.41 |
$11.24K |
12,080 |
| 2025-06-21 |
Fischer Frank M |
Director |
限制性股票授予 (RSU) |
2,281 |
$10.41 |
$23.75K |
589,531 |
| 2025-06-21 |
Geiger Uri |
Director |
限制性股票授予 (RSU) |
1,140 |
$10.41 |
$11.87K |
12,036 |
| 2025-06-21 |
Kumar Rakhi |
Director |
限制性股票授予 (RSU) |
1,440 |
$10.41 |
$14.99K |
15,594 |
| 2025-06-20 |
Williams Patrick F. |
Officer |
未知 |
- |
- |
- |
- |
| 2025-06-20 |
Williams Patrick F. |
Chief Financial Officer |
限制性股票授予 (RSU) |
51,850 |
- |
- |
51,850 |
| 2025-06-06 |
Lacob Joseph |
Director |
限制性股票授予 (RSU) |
8,745 |
$13.15 |
$115K |
8,745 |
| 2025-06-06 |
Fischer Frank M |
Director |
限制性股票授予 (RSU) |
8,745 |
$13.15 |
$115K |
8,745 |
| 2025-06-06 |
Huennekens R Scott |
Director |
限制性股票授予 (RSU) |
8,745 |
$13.15 |
$115K |
8,745 |
| 2025-06-06 |
Geiger Uri |
Director |
限制性股票授予 (RSU) |
8,745 |
$13.15 |
$115K |
8,745 |
| 2025-06-06 |
Andrade Lisa |
Director |
限制性股票授予 (RSU) |
8,745 |
$13.15 |
$115K |
8,745 |
| 2025-06-06 |
Ryan Renee |
Director |
限制性股票授予 (RSU) |
8,745 |
$13.15 |
$115K |
8,745 |
| 2025-06-06 |
Kumar Rakhi |
Director |
限制性股票授予 (RSU) |
8,745 |
$13.15 |
$115K |
8,745 |
| 2025-06-03 |
Morrell Martha |
Chief Medical Officer |
RSU 预扣税 |
1,338 |
$13.54 |
$18.12K |
85,943 |
| 2025-06-03 |
Kuhn Rebecca |
Chief Financial Officer |
RSU 预扣税 |
1,337 |
$13.54 |
$18.1K |
131,613 |
| 2025-05-27 |
Becker Joel |
Chief Executive Officer |
RSU 预扣税 |
1,126 |
$12.66 |
$14.26K |
105,338 |
| 2025-05-27 |
Morrell Martha |
Chief Medical Officer |
RSU 预扣税 |
357 |
$12.66 |
$4.52K |
87,281 |
| 2025-05-27 |
Kuhn Rebecca |
Chief Financial Officer |
RSU 预扣税 |
357 |
$12.66 |
$4.52K |
132,950 |
| 2025-05-20 |
Morrell Martha |
Chief Medical Officer |
RSU 预扣税 |
3,051 |
$17.99 |
$54.89K |
87,638 |
| 2025-05-20 |
Kuhn Rebecca |
Chief Financial Officer |
RSU 预扣税 |
3,051 |
$17.99 |
$54.89K |
133,307 |
| 2025-05-14 |
Orbimed Advisors Llc |
10 Percent Owner |
知情卖出 |
34,000 |
$15.94 |
$541.96K |
3,238,199 |
| 2025-04-22 |
Morrell Martha |
Chief Medical Officer |
RSU 预扣税 |
237 |
$10.94 |
$2.59K |
90,689 |
| 2025-04-22 |
Kuhn Rebecca |
Chief Financial Officer |
RSU 预扣税 |
237 |
$10.94 |
$2.59K |
136,358 |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
